BioNTech schließt Serie A Finanzierung über USD 270 Millionen ab

Mainz, 4. Januar 2018 – Die BioNTech AG, ein vollständig integriertes…

BioNTech to Present at 36th Annual J.P. Morgan Healthcare Conference

Mainz, Germany, December 21, 2017 – BioNTech AG, a fully-integrated…

BioNTech Honored as WuXi AppTec Biotech Company of the Year at Scrip Awards 2017

Mainz, Germany, November 30, 2017 – BioNTech AG, a fully-integrated…

BioNTechs Produktionstochter EUFETS wird zu BioNTech Innovative Manufacturing Services

Mainz, Deutschland, 4. Oktober 2017 – Die BioNTech AG, ein…

BioNTech AG to Present at Cantor Fitzgerald Healthcare Conference

Mainz, Germany, September 19, 2017 – BioNTech AG, a fully integrated…

BioNTech meldet positive Ergebnisse einer internationalen Reproduzierbarkeitsstudie mit MammaTyper®

Internationale Multicenter-Studie in zehn Pathologien in…

EU-funded consortium led by BioNTech and Immatics announces completion of regular study treatment in the GAPVAC-101 trial

Mainz/Tuebingen, Germany, 24th March 2017: BioNTech AG and Immatics…

BioNTech to present interim Phase I/II date for mRNA vaccine at AACR

Mainz, Germany, March 7, 2017 - BioNTech AG, a fully-integrated…

BioNTech präsentiert auf der Cowen and Company’s 37th Annual Health Care Conference

Mainz, Germany, February 22, 2017: BioNTech AG, a fully integrated…

BioNTech to Present at 35th Annual J.P. Morgan Healthcare Conference 2017

Mainz, Germany, 22nd December 2016: BioNTech AG, a fully integrated…